Stockscreener 앱 받기
5.21
4.23%
-0.23
시장 영업 전:
5.07
-0.14
-2.69%
Karyopharm Therapeutics Inc (KPTI) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
22.63%
34.08
|
44.04 | 37.93 | 30.02 | 38.78 |
Operating Expenses
|
12.39%
51.92
|
59.26 | 62.32 | 63.27 | 65.07 |
| Benefits Costs and Expenses |
76.76%
136.34
|
77.14 | 75.14 | 53.44 | 70.83 |
| Costs And Expenses |
76.76%
136.34
|
77.14 | 75.14 | 53.44 | 70.83 |
| Operating Income/Loss |
17.24%
-17.84
|
-15.22 | -24.39 | -33.26 | -26.28 |
| Nonoperating Income/Loss |
372.34%
-84.42
|
-17.87 | -12.82 | 9.83 | -5.761 |
| Income/Loss From Continuing Operations Before Tax |
209.02%
-102.27
|
-33.09 | -37.21 | -23.43 | -32.04 |
| Income Tax Expense/Benefit |
297.06%
-0.067
|
0.034 | 0.04 | 0.036 | 0.028 |
| Income/Loss From Continuing Operations After Tax |
208.50%
-102.20
|
-33.13 | -37.25 | -23.46 | -32.07 |
|
Net Income/Loss
|
208.50%
-102.20
|
-33.13 | -37.25 | -23.46 | -32.07 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
72.91%
0.00235
|
0.00867 | 0.00862 | 0.00847 | 0.125 |
| Diluted Average Shares |
72.91%
0.00235
|
0.00867 | 0.00862 | 0.00847 | 0.125 |
| Basic Earnings Per Share |
83.25%
-7.00
|
-3.82 | -4.32 | -2.77 | -0.26 |
| Diluted Earnings Per Share |
83.25%
-7.00
|
-3.82 | -4.32 | -2.77 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.82%
자본화:
|
볼륨(24시간):